Parkinson's Disease Clinical Trials in Minneapolis, MN

18 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.	N/A	University of Minnesota	<1 mi
Udall Project 2 Aim 2A&C	—	University of Minnesota	<1 mi
Aim 3 Particle Swarm Optimization PIGD	N/A	University of Minnesota	<1 mi
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease	N/A	University of Minnesota	<1 mi
Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease	N/A	University of Minnesota	<1 mi
Sleep-specific DBS Therapy in Parkinson's Disease	N/A	University of Minnesota	<1 mi
Percept Transitions in FOG and PD	N/A	University of Minnesota	<1 mi
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease	N/A	University of Minnesota	<1 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease	—	AbbVie	<1 mi
Pathways Mediating Impaired Postural Control in Parkinson's Disease	—	University of Minnesota	<1 mi
Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease	—	VA Office of Research and Development	<1 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis	Phase 4	VA Office of Research and Development	<1 mi
Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst	—	University of Minnesota	<1 mi
Neuroplasticity in Parkinson's Disease	—	University of Minnesota	<1 mi
Sustained Release Oral Formulation for Treatment of Parkinson's Disease	Early 1	University of Minnesota	<1 mi
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease	Phase 2	Intra-Cellular Therapies, Inc.	5 mi
Parkinson's Foundation PD GENEration Genetic Registry	—	Parkinson's Foundation	5 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease	Phase 2	Neuron23 Inc.	5 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.